MCC
CPRX

Money Concepts Capital’s Catalyst Pharmaceutical CPRX Stock Holding History

Money Concepts Capital’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Sell
8,634
-796
-8% -$23.5K 0.01% 541
2026
Q1 		$233K Buy
+9,430
New +$225K 0.01% 511
2023
Q1 		– Sell
-400
Closed -$7.44K – 948
2022
Q4 		$7.44K Buy
400
+173
+76% +$2.66K ﹤0.01% 2168
2022
Q3 		$3K Buy
+227
New +$2.69K ﹤0.01% 1303

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Money Concepts Capital's CPRX Position: Q2 2026 in Review

Money Concepts Capital reduced its Catalyst Pharmaceutical (CPRX) stake by 8.4% in Q2 2026, selling an estimated $23.5K and leaving 8,634 shares worth $271K. The position accounts for 0.01% of the portfolio, ranked #541.

Money Concepts Capital first reported a position in CPRX in Q3 2022 and has held it in 4 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Money Concepts Capital held 8,634 shares of Catalyst Pharmaceutical worth $271K as of Q2 2026.
  • Money Concepts Capital sold 796 Catalyst Pharmaceutical shares in Q2 2026, an estimated $23.5K.
  • Catalyst Pharmaceutical made up 0.01% of Money Concepts Capital's portfolio in Q2 2026, its #541 holding.
  • Money Concepts Capital first reported a position in Catalyst Pharmaceutical in Q3 2022 and has held it in 4 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Money Concepts Capital's 13F filing for Q2 2026, filed 4 Aug 2026.